Metoclopramide

Critical Warnings & Restrictions

Basic Metoclopramide Information

• INN (International Nonproprietary Name): Metoclopramide.
• Brand Names Available In Australia: not specified.
• ATC Code: A03FA01 — Metoclopramide.
• Forms & Dosages: Tablets 5 mg and 10 mg, orally dispersible tablets, oral solutions (e.g. 5 mg/5 mL), and ampoules/vials 10 mg/2 mL for IM/IV.
• Manufacturers In Australia: not specified.
• Registration Status In Australia: not specified.
• OTC / Rx Classification: Prescription Only (Rx) in most markets.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Are you worried about serious movement disorders with metoclopramide?

Prioritise patient protection when prescribing metoclopramide because prolonged use carries recognised serious risks such as tardive dyskinesia, extrapyramidal symptoms and, rarely, neuroleptic malignant syndrome.

Elderly patients are at higher risk of extrapyramidal adverse effects and need lower doses and close monitoring.

Patients with hepatic or renal impairment require dose reductions and careful review because clearance may be reduced.

Pregnancy and breastfeeding require a specialist risk–benefit discussion because metoclopramide increases prolactin and may have neonatal effects with prolonged exposure.

• Absolute Contraindications: hypersensitivity to metoclopramide or excipients.
• Absolute Contraindications: pheochromocytoma.
• Absolute Contraindications: seizure disorders.
• Absolute Contraindications: gastrointestinal haemorrhage, mechanical obstruction or perforation.
• Absolute Contraindications: prior history of tardive dyskinesia with neuroleptics or metoclopramide.
• Relative Contraindications: Parkinson’s disease and other movement disorder predisposition.
• Relative Contraindications: history of depression or mood disorders.
• Relative Contraindications: significant renal or hepatic impairment and advanced age.

Prescriber Checklist Before Issuing A Script:

• Confirm drug history including prior antipsychotic or metoclopramide exposure.
• Ask about any history of movement disorders or unexplained involuntary movements.
• Review seizure history and current anticonvulsant therapy.
• Check renal function (eGFR) and hepatic status and plan dose adjustments if needed.
• For people of childbearing potential, discuss pregnancy risk and consider a pregnancy test when clinically indicated.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Can metoclopramide affect your ability to drive or work safely?

Metoclopramide can cause drowsiness, dizziness and fatigue which may impair driving and operation of heavy machinery.

Advise patients not to drive or operate safety‑critical equipment until they know how the medicine affects them.

Employers and safety‑sensitive workers must follow workplace policies and ensure fitness for duty under Australian workplace safety law.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No until you know your reaction.

Metoclopramide can cause drowsiness and dizziness and Australian road rules require drivers to be unimpaired.

Do not drive, operate machinery, or perform safety‑critical duties until you are certain you are unimpaired.

Usage Basics

INN, ATC And Brand Names Available In Australia

What exactly is this medicine and how is it classified?

INN

Metoclopramide.

ATC

A03FA01 — Metoclopramide, a propulsive and antiemetic agent.

Drug Class

Dopamine D2 receptor antagonist with 5‑HT3 antagonist and 5‑HT4 agonist activity; a prokinetic and antiemetic.

• Common Australian Forms And Suppliers: generic metoclopramide tablets 5 mg and 10 mg, oral solutions and injectable ampoules are the usual presentations.
• International Brand Names Noted In Literature Include Reglan, Primperan and Maxolon, which reflect the same active ingredient.
• Packaging may vary and typically includes blisters of 10–50 tablets or bottles of oral solution and boxes of ampoules for IM/IV use.

The pill called metoclopramide tablets 10 mg is commonly used for acute nausea relief in primary care and emergency settings.

Legal Classification (TGA‑Approved, PBS‑Listed)

Is metoclopramide subsidised or prescription only in Australia?

Metoclopramide is a prescription‑only medicine and governed by the relevant Australian regulatory framework.

PBS subsidy status varies by indication and formulation and clinicians and patients should check PBS listings and the ARTG for current subsidy and restriction criteria.

• Patient Checklist: Ask your prescriber or pharmacist about current PBS status.
• Patient Checklist: Obtain an e‑prescription for telehealth dispensing if needed.
• Patient Checklist: Check the ARTG entry or ask the pharmacist to verify registration and supply options.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

How should metoclopramide be dosed for common problems?

Typical treatment duration is five days or less for most indications and the product should not be used for more than 12 weeks because of tardive dyskinesia risk.

Adjustments For Comorbidities

How do you change doses for children, older adults or organ impairment?

• Children 1–18 years: 0.1–0.15 mg/kg per dose every 8 hours, max 0.5 mg/kg/day and max 10 mg per dose.
• Elderly: use a reduced dose and monitor closely for extrapyramidal effects and drowsiness.
• Hepatic impairment: consider a 50% dose reduction and monitor for adverse effects.
• Renal impairment: reduce dose by 50% if estimated GFR is less than 40 mL/min.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is almost time for the next dose.

Do not double the next dose to make up for a missed dose.

If you suspect an overdose or notice severe drowsiness, agitation, or involuntary movements, seek emergency care immediately.

• Missed Dose Checklist: Take it soon if safe; skip if near next dose.
• Overdose Action Checklist: Seek emergency care and mention metoclopramide to clinicians.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Will what you eat or drink change how metoclopramide affects you?

Alcohol and other central nervous system depressants can increase drowsiness and dizziness when taken with metoclopramide.

Caffeine does not prevent sedative effects and may mask fatigue while impairment persists.

Patients who drink socially or work night shifts should avoid alcohol while taking metoclopramide.

• Lifestyle Interaction: Avoid alcohol while taking metoclopramide.
• Lifestyle Interaction: Be cautious with sedating medications such as some antihistamines or benzodiazepines.
• Checklist For Safety‑Sensitive Workers: Confirm fitness for duty before shift start and avoid alcohol during therapy.

Common Drug Conflicts

Which medicines worsen risks when combined with metoclopramide?

User Reports & Trends (Australian Patient Feedback)

What are Australians saying about metoclopramide?

• Positive Themes: Rapid relief of acute nausea, particularly for post‑operative, migraine, or short‑term gastroenteritis nausea.
• Positive Themes: Appreciated availability of metoclopramide injectable in hospital settings for rapid control.
• Negative Themes: Drowsiness and fatigue reported by a number of users after dosing.
• Negative Themes: Occasional restlessness, akathisia or involuntary movements especially with repeated dosing.
• Negative Themes: Strong caution expressed about prolonged use because of movement disorder risk.
• Access/Cost Themes: Concerns about availability of injectable forms in rural areas and price sensitivity tied to PBS subsidy status.

When To Report Side Effects:

• Report new involuntary movements immediately, especially if they are persistent.
• Report severe drowsiness, confusion, or signs of neuroleptic malignant syndrome urgently.
• Report timing and drug details to the pharmacist or prescriber, and consider TGA adverse event reporting.

Access & Purchase Options (Australia)

National Chains And Community Pharmacies

Where can Australians get metoclopramide safely?

Major outlets such as Chemist Warehouse, Priceline and TerryWhite Chemmart stock prescription medicines and can supply metoclopramide with a valid prescription.

Local independents may also stock generic metoclopramide tablets, oral solutions and can arrange supplies of injectables via hospital channels.

• Buying Safely Checklist: Check the ARTG entry or ask the pharmacist to verify product registration.
• Buying Safely Checklist: Avoid unregulated overseas sellers that do not supply ARTG‑registered products.
• Buying Safely Checklist: If eligible, ask about PBS concessions to reduce out‑of‑pocket cost.

Online Pharmacies And Telehealth E‑Prescriptions

Is online ordering safe and reliable for metoclopramide?

E‑prescriptions and telehealth have increased accessibility to prescription medicines in Australia through verified providers.

Ensure online pharmacies are Australian‑based and comply with AHPRA and TGA requirements before ordering.

In our online pharmacy, metoclopramide is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

Simplified Explanation

How does metoclopramide work in plain language?

Metoclopramide blocks dopamine D2 receptors in the chemoreceptor trigger zone which raises the threshold for vomiting.

It also acts as a 5‑HT3 receptor antagonist and a 5‑HT4 receptor agonist, which helps improve gastric motility and accelerate gastric emptying.

Because it increases prolactin it can cause endocrine effects with prolonged exposure.

Suggested Diagram: Gut motility arrows pointing right and a brain chemoreceptor with an inhibitory arrow showing reduced vomiting reflex.

D2 Antagonism

Reduces nausea by acting on the chemoreceptor trigger zone.

5‑HT3 Antagonism

Contributes to antiemetic effect in some contexts.

5‑HT4 Agonism

Promotes gastric emptying and pyloric relaxation.

Clinical Terms (What It Means For Patients)

Expect faster gastric emptying and relief from nausea in many short‑term cases.

Possible endocrine effects include increased prolactin which can rarely cause galactorrhoea or gynecomastia with prolonged use.

CNS penetration explains the risk of extrapyramidal symptoms and tardive dyskinesia, particularly with long or high‑dose exposure.

• Pharmacological Effects: Antiemetic, prokinetic, and prolactin elevation potential.
• One‑Line Takeaway For Prescribers: Use short courses at the lowest effective dose and monitor for movement disorders.

Indications & Off‑Label Uses

Approved Indications By TGA (And Common Hospital Practice)

What is metoclopramide commonly used for in clinical practice?

Off‑Label Uses In Australian Clinical Practice

Short‑term off‑label use can be appropriate in refractory nausea in palliative care or perioperative settings with clear documentation.

A checklist for prescribers using metoclopramide off‑label includes evidence review, documented informed consent and a monitoring plan for movement disorders.

• Prescriber Checklist: Document the clinical rationale and expected duration.
• Prescriber Checklist: Obtain informed consent and explain movement disorder risks.
• Prescriber Checklist: Arrange early follow‑up and monitoring for adverse effects.

Key Clinical Findings (Evidence Summary)

What does the evidence say about effectiveness and safety?

Randomised trials and systematic reviews show metoclopramide is effective for acute nausea and accelerates gastric emptying in gastroparesis.

Benefits are balanced against well‑documented risks of extrapyramidal side effects and tardive dyskinesia with prolonged exposure.

Regulatory guidance in recent years emphasises limiting treatment duration and monitoring for movement disorders.

• Clinical Takeaway: Effective for short‑term control of nausea and for prokinetic use in selected patients.
• Clinical Takeaway: Limit duration and avoid long‑term therapy when possible.
• Clinical Takeaway: Monitor elderly patients and those with renal or hepatic impairment closely.

Research Note: Clinicians should consult up‑to‑date TGA and peer‑reviewed sources and local gastroenterology guidance for 2022–2026 updates before prolonged use.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Pros And Cons Checklist

• Metoclopramide Pros: Effective, inexpensive, available in oral and injectable forms.
• Metoclopramide Cons: CNS side effects, prolactin elevation and strict duration limits.
• Domperidone Pros: Fewer CNS effects in many patients.
• Domperidone Cons: Cardiac risks and screening requirements.
• Ondansetron Pros: Effective for chemotherapy and postoperative nausea.
• Ondansetron Cons: Cost and PBS restrictions depending on indication.
• Decision Checklist For Prescribers: Consider patient risk profile, indication, monitoring capacity and PBS coverage.

Common Questions (Australian Pharmacy Consultations)

Which questions do patients ask most often at the pharmacy?

• Can pregnant or breastfeeding people take it? — Discuss increased prolactin and seek specialist advice; use only if benefits outweigh risks.
• Is it safe for children? — Dosing exists for children 1–18 years but follow paediatric guidance and specialist advice.
• How long can I take it? — Typically ≤5 days and avoid more than 12 weeks because of tardive dyskinesia risk.
• What should I watch for? — New restlessness, involuntary movements, muscle rigidity, severe drowsiness; seek urgent review if these occur.

Printable Patient Checklist: Dose, duration, key side effects to report and emergency signs to seek immediate care for.

Price & Access Comparison Table (How To Present)

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

• Confirm pack size and formulation before ordering.
• Check PBS concession eligibility to reduce cost.
• Verify the pharmacy’s ARTG authorisation and pharmacist verification for online orders.
• Ask about delivery options and hospital channels for injectables in rural areas.

Registration & Regulation

TGA Approval And Safety Communications

How is metoclopramide regulated in Australia?

Metoclopramide is regulated as a prescription medicine and its ARTG entry should be checked for current sponsor and formulation details.

Australian regulatory guidance mirrors international concerns and emphasises limiting duration and informing patients about movement disorder risks.

Adverse events should be reported to the TGA and local hospital drug safety committees for pharmacovigilance.

PBS Subsidy Details & Prescribing Restrictions

PBS listing and authority requirements depend on the indication and formulation and clinicians should confirm current PBS criteria.

For off‑label and specialised uses, ensure documentation, informed consent and complete any required authority paperwork.

• Prescriber Checklist: Confirm ARTG details and PBS schedule before prescribing for subsidy.
• Prescriber Checklist: Complete authority paperwork if required and document informed consent.
• Prescriber Checklist: Counsel the patient and document counselling in the record.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

How should patients store metoclopramide at home?

Store tablets and solutions at 15–30°C and protect them from light and moisture.

In hot or humid Australian summers, keep medicines in the original packaging in a cool, dry place away from cars and bathrooms.

After opening oral solution follow the manufacturer’s label for use‑by period.

• Do: keep the bottle or blister pack in a cool cupboard, out of direct sunlight.
• Do Not: store in a parked car or in a bathroom where heat and humidity fluctuate.
• Travel Checklist: Use insulated packing for long exposure to heat and avoid freezing.

Cold‑Chain And Pharmacy Handling

What about injectable supply handling?

Injectable ampoules should not be frozen and must be transported per manufacturer instructions where refrigeration is required.

Document any cold‑chain breaches and discard product if storage conditions fall outside recommended ranges.

• Pharmacy Checklist: Maintain temperature logs and rotate stock by expiry.
• Pharmacy Checklist: Advise patients on safe transport and storage of dispensed injectable products if applicable.

Guidelines For Proper Use (Counselling & Monitoring)

Australian Pharmacist Counselling Style

What should pharmacists tell patients at the counter?

Confirm the indication and explain the intended short duration of therapy, ordinarily five days or less unless a specialist advises otherwise.

Explain dosing: for most adults 10 mg up to three times daily and to take the medicine as directed.

Warn about drowsiness and avoid alcohol while taking the medicine.

Advise patients to stop the medicine and seek assessment if they notice unusual movements, severe muscle stiffness or persistent restlessness.

• Patient Counselling Checklist: Dose, duration, missed dose advice, and key side effects to report.
• Suggested Script: “Take 10 mg up to three times a day; stop and call us if you notice unusual movements.”

Patient Advice From PBS And National Health Authorities

Where can patients find authoritative safety information?

Patients should follow TGA safety communications and PBS guidance for subsidy details and reporting requirements.

Report adverse events to the TGA and seek specialist referral for persistent symptoms or consideration of chronic therapy.

For long‑term management of gastroparesis coordinate care with gastroenterology and endocrinology as appropriate.

• Printable Patient Checklist: Dose, duration, side effects to report and emergency signs.
• Patient Action: Keep medication details and prescriber contact information handy when reporting side effects.

Delivery Across Australia

Conclusion And Practical Takeaways

Metoclopramide is an effective short‑term antiemetic and prokinetic when used appropriately.

Limit treatment duration, use the lowest effective dose and monitor for extrapyramidal symptoms, especially in the elderly and those with organ impairment.

Check PBS and ARTG details before prescribing and counsel patients clearly about drowsiness and movement disorder risks.

For alternatives consider domperidone or ondansetron depending on the clinical situation and patient risk profile.

Report adverse events to the TGA and ensure informed consent for off‑label or prolonged use.